Reduced frataxin expression was also found to be correlated with increased p16INK4 in lung sections from patients with both PAH and PH associated with lung disease (Group 3 PH), as well as in animal models of PAH and Group 2 PH. This evidence concerns the gene CDKN2A and pulmonary arterial hypertension.